Shareholders of AstraZeneca PLC Should Contact Levi & Korsinsky Before February 21, 2025 to Discuss Your Rights – AZN

Core Viewpoint - A class action securities lawsuit has been filed against AstraZeneca PLC, alleging securities fraud that negatively impacted investors between February 23, 2022, and December 17, 2024 [1][2]. Group 1: Lawsuit Details - The complaint claims that AstraZeneca engaged in insurance fraud in China, leading to increased legal exposure and the detention of the AstraZeneca China President by law enforcement [2]. - It is alleged that AstraZeneca understated its legal risks, and the revelations could materially harm its business activities in China [2]. - The defendants' statements regarding AstraZeneca's business, operations, and prospects are claimed to be materially false and misleading [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until February 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].